PHARPharming Group N.V.

Healthcare
$9.70-34% 1Y

The financials

Pharming Group N.V. by the numbers

For the full year FY2025, revenue was $376M (+27% year on year) and net income $2.5M.

Biotechnology

Ranks #16 of 196 by RyuScore

Compare peers
MDXG+0.22%
MIMEDX GROUP, INC.
OLMA-1.5%
Olema Pharmaceuticals, Inc.
OABI+1.9%
OmniAb, Inc.
AURA+0.62%
Aura Biosciences, Inc.
SLDB-0.51%
Solid Biosciences Inc.
GUTS-7.4%
FRACTYL HEALTH, INC.